http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2411353-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8770bb818846ebe613eb735284c8b5a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
filingDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a91feb15502afcbd005d7df405c4aaf
publicationDate 2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2411353-A
titleOfInvention Resveratrol Analogues
abstract Compounds for use in the treatment of conditions associated with angiogenesis or for diseases associated with cyclooxygenase-2 (COX-2) of the formula: <EMI ID=1.1 HE=36 WI=50 LX=278 LY=762 TI=CF> <PC>wherein when R1 is H or OH, R2 is 3-methylbut-1-enyl, 3-methylbut-2-enyl or similar; and when R1 is OH, R2 is a hydrocarbon chain; and analogues thereof. Thus these compounds may be useful in the treatment of conditions associated with inflammation, angiogenesis and tumour growth.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103649031-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10696615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634375-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352310-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107266297-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012149608-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107266297-A
priorityDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0214252-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0121165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03009807-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0142231-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004031117-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487318
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID442942
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11239
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3621
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID754102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID246227
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39376
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID469616
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID443460
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53395097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414670294
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID754102
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID96455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421705908
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396451
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54057918
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100135607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19225
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID96455
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419644918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467443276

Total number of triples: 58.